Svetlana Vinokurova
Overview
Explore the profile of Svetlana Vinokurova including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
1056
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dugina V, Vasileva M, Khromova N, Vinokurova S, Shagieva G, Mikheeva E, et al.
Int J Mol Sci
. 2024 Apr;
25(8).
PMID: 38674115
The widespread occurrence of breast cancer and its propensity to develop drug resistance highlight the need for a comprehensive understanding of the molecular mechanisms involved. This study investigates the intricate...
2.
Kisseljova N, Zhordania K, Fedorova M, Katargin A, Valeeva A, Pajanidi J, et al.
Intervirology
. 2020 Feb;
62(5-6):198-204.
PMID: 32088719
Background/aims: High-risk human papillomavirus (HPV) infection is associated with different malignancies, but its role in the pathogenesis of ovarian cancer remains inconclusive. Published studies demonstrated a wide variation (0-50%) in...
3.
Stich M, Ganss L, Puschhof J, Prigge E, Reuschenbach M, Guiterrez A, et al.
Oncotarget
. 2017 Sep;
8(32):52104-52117.
PMID: 28881717
High-risk human papillomaviruses (hr HPVs) may cause various human cancers and associated premalignant lesions. Transformation of the host cells is triggered by overexpression of the viral oncogenes E6 and E7...
4.
Vinokurova S
Curr Pharm Des
. 2017 Aug;
23(32):4842-4861.
PMID: 28828983
About 15-20% of human cancers worldwide have viral etiology. Seven human DNA and RNA viruses are accepted to be oncogenic viruses or oncoviruses and contribute to the development of various...
5.
Bodelon C, Untereiner M, Machiela M, Vinokurova S, Wentzensen N
Int J Cancer
. 2016 Jun;
139(9):2001-11.
PMID: 27343048
Persistent infection with carcinogenic human papillomaviruses (HPV) causes the majority of anogenital cancers and a subset of head and neck cancers. The HPV genome is frequently found integrated into the...
6.
Bodelon C, Vinokurova S, Sampson J, den Boon J, Walker J, Horswill M, et al.
Carcinogenesis
. 2015 Dec;
37(2):188-196.
PMID: 26660085
No abstract available.
7.
Fedorova M, Vinokurova S, Pavlova L, Komelkov A, Korolenkova L, Kisseljov F, et al.
Virology
. 2015 Dec;
488:196-201.
PMID: 26655237
High-risk human papillomavirus (HR-HPV) persistent infection is responsible for the development of the majority of cervical cancers. The therapy against HPV-associated cancer requires knowledge of the viral gene expression mechanisms....
8.
Reuschenbach M, Huebbers C, Prigge E, Lorenzo Bermejo J, Kalteis M, Preuss S, et al.
Cancer
. 2015 Mar;
121(12):1966-76.
PMID: 25731880
Background: The human papillomavirus (HPV) E2 protein is a transcriptional repressor of the oncogenes E6/E7 and loss of E2 function is considered a key step in carcinogenesis. Integration of HPV...
9.
Prigge E, Toth C, Dyckhoff G, Wagner S, Muller F, Wittekindt C, et al.
Int J Cancer
. 2014 Aug;
136(7):1589-99.
PMID: 25104331
p16(INK4a) immunohistochemical overexpression is an overall reliable surrogate marker of human papillomavirus (HPV)-associated head and neck squamous cell carcinomas (HNSCC). However, cases of ambiguous p16(INK4a) overexpression are regularly detected in...
10.
Thomas L, Lorenzo Bermejo J, Vinokurova S, Jensen K, Bierkens M, Steenbergen R, et al.
Eur J Cancer
. 2013 Sep;
50(1):85-98.
PMID: 24054023
Background: Overexpression of the human papillomavirus (HPV) oncogenes E6 and E7 is necessary for the development of distinct lower genital tract cancers. However, secondary cellular genomic alterations are mandatory to...